• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail

  • Print
  • Share
  • E-mail
Pediatric Labeling Date:  11/21/2007
Trade Name:  Omnaris Nasal Spray
Generic Name or Proper Name (*):  ciclesonide
Indications Studied:  Treatment of seasonal allergic rhinitis (SAR) in patients 6 through less than 12 years of age
Label Changes Summary:  * Indication extended down to 6 years of age * Pediatric dosing information provided * Two clinical studies evaluated safety in children 6 to 11 years of age and the overall incidence of adverse events was comparable to those treated with placebo * Efficacy in children 2 to 5 years of age was not established in clinical trials conducted in this age group. * Waiver of studies in children ages 0 to less than 2 years of age for SAR because of local and systemic safety concerns as well as lack of disease and/or diagnosis difficulties in children * New indication
Product Labeling:  Labeling  Opens a new window
Sponsor:  Nycomed US Inc.
Therapeutic Category:  Antiasthmatic; antiallergy